Ryan Specialty Holdings, Inc. (NYSE:RYAN – Get Free Report) EVP Mark Stephen Katz sold 14,790 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $71.39, for a total value of $1,055,858.10. Following the sale, the executive vice president now directly owns 12,386 shares of the company’s stock, valued at $884,236.54. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
Ryan Specialty Price Performance
Shares of NYSE:RYAN opened at $71.62 on Wednesday. Ryan Specialty Holdings, Inc. has a one year low of $41.49 and a one year high of $73.10. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The firm has a market capitalization of $18.75 billion, a price-to-earnings ratio of 93.01, a PEG ratio of 1.62 and a beta of 0.62. The company’s fifty day moving average price is $67.85 and its 200-day moving average price is $61.53.
Ryan Specialty (NYSE:RYAN – Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.41. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The business had revenue of $604.69 million for the quarter, compared to the consensus estimate of $602.04 million. During the same quarter last year, the business posted $0.32 earnings per share. The company’s revenue for the quarter was up 20.5% on a year-over-year basis. On average, equities research analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.8 earnings per share for the current fiscal year.
Ryan Specialty Dividend Announcement
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on the company. Citigroup upped their target price on Ryan Specialty from $56.00 to $62.00 and gave the company a “neutral” rating in a report on Tuesday, July 23rd. UBS Group boosted their target price on Ryan Specialty from $67.00 to $76.00 and gave the company a “buy” rating in a research note on Tuesday, August 13th. BMO Capital Markets raised shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and upped their price objective for the company from $65.00 to $75.00 in a report on Tuesday, September 24th. JPMorgan Chase & Co. lifted their target price on shares of Ryan Specialty from $54.00 to $56.00 and gave the stock an “underweight” rating in a research note on Friday, August 2nd. Finally, Wells Fargo & Company upped their price target on shares of Ryan Specialty from $63.00 to $70.00 and gave the company an “equal weight” rating in a research note on Thursday, October 10th. One analyst has rated the stock with a sell rating, five have issued a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $70.33.
Check Out Our Latest Stock Report on RYAN
Hedge Funds Weigh In On Ryan Specialty
Several institutional investors and hedge funds have recently made changes to their positions in RYAN. Securian Asset Management Inc. bought a new position in shares of Ryan Specialty during the second quarter valued at about $474,000. Xponance Inc. boosted its holdings in Ryan Specialty by 67.2% during the 2nd quarter. Xponance Inc. now owns 20,686 shares of the company’s stock valued at $1,198,000 after acquiring an additional 8,312 shares during the period. Geneva Partners LLC bought a new position in Ryan Specialty during the 3rd quarter worth approximately $2,537,000. Susquehanna Fundamental Investments LLC increased its stake in Ryan Specialty by 2,354.0% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 100,614 shares of the company’s stock worth $5,827,000 after purchasing an additional 96,514 shares during the period. Finally, Retirement Systems of Alabama bought a new stake in Ryan Specialty in the second quarter valued at approximately $7,316,000. Institutional investors own 84.82% of the company’s stock.
Ryan Specialty Company Profile
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Further Reading
- Five stocks we like better than Ryan Specialty
- How to Calculate Stock Profit
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- Why Are Stock Sectors Important to Successful Investing?
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.